Product Images Valganciclovir Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with Valganciclovir Hydrochloride NDC 72205-019 by Novadoz Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

valganciclovir-50mg-100ml-cntr-label - valganciclovir 50mg 100ml cntr label

valganciclovir-50mg-100ml-cntr-label - valganciclovir 50mg 100ml cntr label

Valganciclovir for oral solution is a prescription drug that contains 50 mg/ml of valganciclovir free base. It is used as per the instructions provided in the package insert. The dry powder should be stored at 68°F to 77°F. While storing the constituted solution, it should be kept under refrigeration at 36°F to 46°F. The constituted oral solution can be used within 49 days of preparation after writing the discard date on the bottle label. It is distributed by Novadoz Pharmaceuticals LLC and manufactured by MSN Pharmaceuticals Inc.*

valganciclovir-50mg-100ml-crtn-label - valganciclovir 50mg 100ml crtn label

valganciclovir-50mg-100ml-crtn-label - valganciclovir 50mg 100ml crtn label

Valganciclovir for Oral Solution is a medicine that comes in a dry powder form and requires water to be added before use. After the powder is mixed with purified water, each mL of the oral solution contains 50 mg valganciclovir free base. The solution should not be stored beyond 49 days post-preparation and should be kept in its original bottle under refrigeration until use. The medicine should not be frozen, and any unused portions should be discarded. The box contains one bottle of 12 dry powder units, one adapter, and two oral dispensers. The accompanying patient instructions comprise important prescribing and handling information.*

valganciclovir-dose-calculation-formula - valganciclovir dose calculation formula

valganciclovir-dose-calculation-formula - valganciclovir dose calculation formula

valganciclovir-fig-1 - valganciclovir fig 1

valganciclovir-fig-1 - valganciclovir fig 1

The text appears to be a diagram or illustration of a child-resistant cap bottle with an adapter and an oral dispenser with a plunger. There is not enough information available to provide a more detailed description.*

valganciclovir-fig-10 - valganciclovir fig 10

valganciclovir-fig-10 - valganciclovir fig 10

valganciclovir-fig-11 - valganciclovir fig 11

valganciclovir-fig-11 - valganciclovir fig 11

valganciclovir-fig-12 - valganciclovir fig 12

valganciclovir-fig-12 - valganciclovir fig 12

valganciclovir-fig-2 - valganciclovir fig 2

valganciclovir-fig-2 - valganciclovir fig 2

valganciclovir-fig-3 - valganciclovir fig 3

valganciclovir-fig-3 - valganciclovir fig 3

valganciclovir-fig-4 - valganciclovir fig 4

valganciclovir-fig-4 - valganciclovir fig 4

valganciclovir-fig-5 - valganciclovir fig 5

valganciclovir-fig-5 - valganciclovir fig 5

valganciclovir-fig-6 - valganciclovir fig 6

valganciclovir-fig-6 - valganciclovir fig 6

valganciclovir-fig-7 - valganciclovir fig 7

valganciclovir-fig-7 - valganciclovir fig 7

valganciclovir-fig-8 - valganciclovir fig 8

valganciclovir-fig-8 - valganciclovir fig 8

valganciclovir-formula - valganciclovir formula

valganciclovir-formula - valganciclovir formula

This formula is used to estimate glomerular filtration rate (GFR), a measure of kidney function, in males. The formula considers age, body weight, and serum creatinine levels.*

valganciclovir-structural-formula - valganciclovir structural formula

valganciclovir-structural-formula - valganciclovir structural formula

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.